Clinicopathologic Conference, Copper Deficiency Myelopathy
NEJM 377:1977-1984, Case 35-2017, 2017
Weight Change Associated with Antiepileptic Drugs
JNNP 84:796-799, Pickrell, W.,et al, 2013
Valproic Acid Adjunctive Therapy for HIV-Associated Cognitive Impairment: A First Report
Neurol 66:919-921, Schifitto,G.,et al, 2006
Weight Change Associated with Valproate and Lamotrigine Monotherapy in Patients with Epilepsy
Neurol 56:172-177, Biton,V.,et al, 2001
Valproate, Hyperandrogenism, and Polycystic Ovaries
Arch Neurol 57:1064-1068, Isojarvi,J.I.T. & Tapanainen,J.S., 2000
Obesity and Endocrine Disorders in Women Taking Valproate for Epilepsy
Ann Neurol 39:579-584, 5591996., Isojarvi,J.I.T.,et al, 1996
Reversible Dementia and Apparent Brain Atrophy During Valproate Therapy
Ann Neurol 38:687-691, Papazian,O.,et al, 1995
A Comparison of Valproate with Carbamazepine for the Treat of Complex Partial Seizures & Second General Seizures in Adults
NEJM 327:765-771, Mattson,R.H.,et al, 1992
Myoclonus in Adult Huntington's Disease
Ann Neurol 29:213-215, Vogel,C.M.,et al, 1991
Valproic Acid, Review of a New Antiepileptic Drug
Arch Neurol 36:393-398, Bruni,J.,et al, 1979